Siemens Healthineers Presents Photon-Counting CT Scanner Designed for Radiation Therapy
October 24, 2025
Novel technology delivers enhanced image contrast and resolution for confident decisions
Novel technology delivers enhanced image contrast and resolution for confident decisions
An endoscopy—using a fiber‐optic tube to peer inside the body and collect biopsy samples—can be an invaluable way to detect cancer of the esophagus. But sometimes, an endoscopy can miss esophageal cancer, which doesn’t get detected until weeks or months later.
Researchers have created a new type of drug molecule that can precisely destroy TERRA, an RNA molecule that helps certain cancer cells survive. Using advanced “RIBOTAC” technology, their compound finds TERRA inside cells and breaks it down without harming healthy molecules. This discovery could pave the way for a new generation of RNA-based cancer treatments, targeting the disease at its genetic roots rather than just its symptoms.
Randomized, controlled clinical trials are crucial for telling whether a new treatment is safe and effective. But often scientists don’t fully report the details of their trials in a way that allows other researchers to gauge how well they designed and conducted those studies.
For decades, scientists have thought they understood the biochemical machinery that causes asthma—inflammation in the lungs that constricts airways and makes it hard to breathe.
Melbourne scientists have revealed how hydrogen is made and used in the human gut. Though infamous for making flatulence ignite, hydrogen also has a positive role supporting gut health.
Two teams of researchers have developed a cell reprogramming technology that converts rogue disease-causing T cells from our immune system into protective Tregcells. These cells help ensure that the immune system doesn’t attack the body’s own tissues. The breakthroughs could usher in more personalized and targeted cell therapies for a host of autoimmune diseases.
YORK, S.C., Oct. 23, 2025 /PRNewswire/ — Elkem ASA (ticker: ELK), a global leader in advanced silicon-based materials, today unveiled SILBIONE™ LSR Select EC 70, a next-generation medical-grade liquid silicone rubber. Designed for wearable and diagnostic devices, the material combines high electrical conductivity, certified biocompatibility1, and enhanced process control, setting a new standard for precision healthcare applications.
Ypsomed announced that it launched YpsoLoop, its first autoinjector platform designed for circularity.
Mode Sensors is currently undertaking a Series A funding round to support the US market launch of its wearable sensor.